Adrian De Courcey Email & Phone Number

Argonaute RNA Ltd. is developing safe and reliable methods of temporarily silencing target genes in different tissue cells. Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein.Argonaute RNA research projects build on existing intellectual property. We show how our proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression.We use a novel method of stabilising the siRNA and thereby avoid a range of issues which have hitherto proved significant obstacles to developing siRNA drugs for use in man.

Swansea, Wales, United Kingdom

Kaydiar is an innovative medical device company specialising in medical offloading technology for pressure-induced wounds/lesions and musculoskeletal injuries.https://www.kaydiar.co.uk

London Area, United Kingdom

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers,specializing in epigenomic and genetic analysis.

Merthyr Tydfil, Wales, United Kingdom

Tydfil Training Consortium is a registered charity and training provider (part of the University of South Wales Group). Our charitable objects are to promote the advancement of education and the relief of need among young and other unemployed persons resident in Wales by the provision of such training facilities as will enable such persons to acquire and develop vocational skills.

Coventry, England, United Kingdom

- Created and implemented a strategic plan to restructure business with a commitment to be the most environmentally efficient passenger transport operator in the UK.- Led an international project with stakeholders from the U.S., Holland and Switzerland to develop and operate the first large, fast-charging electric buses in the U.K.- Successfully navigated several operational, technical and financial challenges including the Chapter 11 insolvency of a lithium battery supplier and change in ownership of two key suppliers. Maintained the confidence of public and private sector shareholders to deliver the project.- Negotiated £48.6m of long-term contracts with new customers including Aston Martin, Jaguar Land Rover, Tesco, TUI and the National Exhibition Centre.- Led investment of £24.3m in electric and hybrid vehicles and constriction of a new depot powered entirely by renewable energy.- Secured £4.8m of government grants from the Centre of Excellence for Low Carbon Technologies, the Department of Transport and the Regional Growth Fund. - Changed the company's culture and reward system, linking pay directly with performance through the use of real-time tracking technology to measure and encourage safe and fuel-efficient driving styles. - Implemented new risk management procedures with continuous mentoring, performance incentives and intensive analysis of data which reduced the number of vehicle 'risk events' by 52%. - Through adept use of technology to enter new markets and optimise the cost base, transformed the company's financial performance. Revenues increased by 177% from £6m (2010) to £17m (2017) while the overall market contracted. Profit before tax increased by 1,281% from £87,682 (2010) to £1,210,883 (2017).

Birmingham, England, United Kingdom

The Confederation of Passenger Transport (CPT) is an advocacy group representing operators of the UK buses and coaches. As well as providing services to its members, it acts as a primary voice of the industry to the government on national and international legislation, local regulations, operational practices and engineering standards.

Zug, Switzerland

- Successfully negotiated and resolved a global patent dispute with key partner.- Developed and implemented an EMEA-wide transportation sourcing strategy for all types of transport and all modes (air, ocean, road, rail) for Pharma, medical devices/diagnostics and consumer products. - Managed strategic relationships with key EMEA suppliers.- Created and implemented management dashboards and standardised KPIs to improve performance.

London, England, United Kingdom

- Developed, with stakeholders. a strategy and financial model for Shell's participation in the trading of carbon credits.- Developed a cost model for the supply of Shell's downstream products to the Greek islands.- Evaluated cost saving opportunities in a restructuring of the German distribution network following Sheel's acquisition of DEA Oil.

London, England, United Kingdom

Emba, Master Of Business Administration

Activities and Societies: Dissertation title - 'Ageing Populations - Unaffordable Liability or Underappreciated Opportunity? An analysis.

Education record

Activities and Societies: Was a finalist in the global business strategy competition L'Oreal e-Strat Challenge in Paris (June 2007).

Master Of Arts - Ma, International Political Economy

Dissertation - "Impact of IMF and World Bank Policies on Polish Economy, 1990 - 1994'

Bachelor Of Arts - Ba, Economics And Economic History, 2:1

Won the Ford Memorial Prize for Outstanding Performance in Economic History (1998)